Acumen Pharmaceuticals Inc.

1 trials 1 recruiting Commercial sponsor

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

1 Recruiting

0 Completed trials

3 Countries active

4 Unique IMPs

N/A Results reported

Phase II

Top IMPs

FLORBETABEN (18F) 1 FLORBETAPIR (18F) 1 FLUTEMETAMOL (18F) 1 SABIRNETUG 1

All trials

1 total

A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Intravenous Sabirnetug in Early Alzheime… Recruiting

2023-509807-34-00 Phase II 3 countries FLORBETABEN (18F); FLORBETAPIR (18F); FLUTEMETAMOL (18F); SABIRNETUG

Showing 1–1 of 1 trials

← All sponsors A–Z